15 animals were previously anesthetized by i.p. injection of ketamine (100 mg/Kg) and xylazine (10 mg/Kg). When they were in the no-pain sleep phase, they were intracardially perfused with 4% paraformaldehyde (PFA) diluted in 0.1 M phosphate buffer (PB). After perfusion, brains were removed and stored in 4% PFA at 4 °C overnight (O/N). The next day, the solution was replaced by 4% PFA + 30% sucrose. Coronal sections of 20 μm were obtained by a cryostat (Leica Microsystems, Wetzlar, Germany) and they were kept in a cryoprotectant solution and stored at − 20 °C until use. To perform the experiments, the free-floating technique was used. Briefly, free-floating sections were rinsed in 0.1 M phosphate-buffered saline (PBS) pH 7.35, and after that in PBS-T (PBS 0.1 M, 0.2% Triton X-100). Then they were incubated in a blocking solution (10% fetal bovine serum (FBS), 1% Triton X-100, PBS 0.1 M + 0.2% gelatin) for 1–2 h at room temperature. Later, sections were washed with PBS-T and incubated O/N at 4 °C with the corresponding primary antibody (Table 2). Brain slices were washed with PBS-T and incubated with the corresponding secondary antibody (Table 2) for 2 h at room temperature. Thioflavin-S (ThS) protocol was carried out as previously described [42 (link)]. Finally, sections were treated with 0.1 μg/mL Hoechst (Sigma-Aldrich, St Louis, MO, United States), used for cell nuclei staining, for 8 min in the dark at room temperature and washed with 0.1 M PBS. All reagents, containers and materials exposed to Hoechst were properly handled and processed to avoid any cytotoxic contamination. Ultimately, all the samples were mounted in Superfrost® microscope slides using Fluoromount medium (EMS) and were left to dry O/N. Image acquisition was obtained using an epifluorescence microscope (BX61 Laboratory Microscope, Melville, NY OlympusAmerica Inc.) and quantified by ImageJ. 5 animals per group were analyzed.
Primary and secondary antibodies for Immunofluorescence
Espinosa-Jiménez T., Cano A., Sánchez-López E., Olloquequi J., Folch J., Bulló M., Verdaguer E., Auladell C., Pont C., Muñoz-Torrero D., Parcerisas A., Camins A, & Ettcheto M. (2023). A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet. Cell & Bioscience, 13, 52.
Other organizations :
Universitat de Barcelona, Biomedical Research Networking Center on Neurodegenerative Diseases, Institut d'Investigació Sanitària Pere Virgili, Universitat Internacional de Catalunya
Anesthesia: Ketamine (100 mg/Kg) and xylazine (10 mg/Kg) administered by i.p. injection
dependent variables
Immunofluorescence analysis of GFAP and IBA1 levels in brain sections
control variables
Number of animals per group (5 animals per group)
Perfusion with 4% paraformaldehyde (PFA) diluted in 0.1 M phosphate buffer (PB)
Brain sectioning (coronal sections of 20 μm obtained by cryostat)
Free-floating technique used for immunostaining
Primary and secondary antibodies used for immunofluorescence (see Table 2)
Thioflavin-S (ThS) staining protocol
Hoechst staining for cell nuclei
Mounting of samples on Superfrost® microscope slides using Fluoromount medium
positive controls
Not explicitly mentioned
negative controls
Not explicitly mentioned
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required